Never Run Out Of Buyers To Sell To.

EpiVax has been providing immunogenicity expertise for over 25 years, helping pharmaceutical and biotech teams generate the insights they need to make informed decisions across biologic and vaccine programs. Our work ensures the success of pipelines at every stage, supporting companies ranging from emerging startups to global industry leaders. We take a risk-based, fit-for-purpose approach to immunogenicity assessment, helping developers focus on what matters most during each phase. From early discovery through regulatory submission and beyond, we integrate computational analyses,…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.